Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan M Saavedra

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Cellular and Molecular Neurobiology|September 23, 2011
Angiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disordersJuan M Saavedra
Journal of Hypertension|May 21, 2009
Opportunities and limitations of genetic analysis of hypertensive rat strainsJuan M Saavedra
Cellular and Molecular Neurobiology|February 15, 2003
The future of Latin American scienceJuan M Saavedra
Clinical Science (London, England : 1979)|July 26, 2012
Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disordersJuan M Saavedra
Cellular and Molecular Neurobiology|December 26, 2008
In Memoriam: John William Daly (1933-2008)Juan M Saavedra
Pharmacological Research|May 31, 2020
Angiotensin receptor blockers for the treatment of COVID-19 and its comorbiditiesJuan M Saavedra
Cellular and Molecular Neurobiology|May 10, 2020
COVID-19, Angiotensin Receptor Blockers, and the BrainJuan M Saavedra
Cellular and Molecular Neurobiology|August 3, 2005
Brain angiotensin II: new developments, unanswered questions and therapeutic opportunitiesJuan M Saavedra
Pharmacological Research|April 19, 2020
Angiotensin receptor blockers and COVID-19Juan M Saavedra
Physiology (Bethesda, Md.)|April 27, 2021
Angiotensin Receptor Blockers Are Not Just for Hypertension AnymoreJuan M Saavedra
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Cellular and Molecular Neurobiology|September 23, 2011
Angiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disordersJuan M Saavedra
Journal of Hypertension|May 21, 2009
Opportunities and limitations of genetic analysis of hypertensive rat strainsJuan M Saavedra
Cellular and Molecular Neurobiology|February 15, 2003
The future of Latin American scienceJuan M Saavedra
Clinical Science (London, England : 1979)|July 26, 2012
Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disordersJuan M Saavedra
Cellular and Molecular Neurobiology|December 26, 2008
In Memoriam: John William Daly (1933-2008)Juan M Saavedra
Pharmacological Research|May 31, 2020
Angiotensin receptor blockers for the treatment of COVID-19 and its comorbiditiesJuan M Saavedra
Cellular and Molecular Neurobiology|May 10, 2020
COVID-19, Angiotensin Receptor Blockers, and the BrainJuan M Saavedra
Cellular and Molecular Neurobiology|August 3, 2005
Brain angiotensin II: new developments, unanswered questions and therapeutic opportunitiesJuan M Saavedra
Pharmacological Research|April 19, 2020
Angiotensin receptor blockers and COVID-19Juan M Saavedra
Physiology (Bethesda, Md.)|April 27, 2021
Angiotensin Receptor Blockers Are Not Just for Hypertension AnymoreJuan M Saavedra
Pageof 10